Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vitacoenzyme is a therapeutic and nutritional compound preparation produced by the fermentation of soybean residue using the fungus *Eremothecium ashbyii*. It is chemically heterogeneous, containing riboflavin (vitamin B2) and its derivatives (such as flavin mononucleotide and flavin adenine dinucleotide) as its primary active components, along with multiple other vitamins (particularly vitamin E), 18 amino acids, and 23 trace elements. In China, vitacoenzyme tablets are approved for the treatment of chronic atrophic gastritis, superficial gastritis, and esophageal epithelial hyperplasia, and are used to prevent precancerous lesions and gastric cancer. It is also utilized as an adjuvant therapy for various types of hepatitis and riboflavin deficiency. Vitacoenzyme acts by supplying essential coenzymes for tissue respiration, promoting mucosal cell growth, improving gastrointestinal immunity, and protecting the gastric mucosa.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on vitacoenzyme.